207 related articles for article (PubMed ID: 23423185)
21. [Digoxin. The drug of choice for the in-utero treatment of paroxysmal supraventricular tachycardia].
Silva IS; Nunes C; Mimoso G; Castela E; Mesquita J
Acta Med Port; 1997 Jan; 10(1):95-8. PubMed ID: 9245185
[TBL] [Abstract][Full Text] [Related]
22. Rate-based management of fetal supraventricular tachycardia.
Guntheroth WG; Cyr DR; Shields LE; Nghiem HV
J Ultrasound Med; 1996 Jun; 15(6):453-8. PubMed ID: 8738990
[TBL] [Abstract][Full Text] [Related]
23. Treatment of fetal supraventricular tachycardia with flecainide acetate after digoxin failure.
Mills M
Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 1):1863. PubMed ID: 1615996
[No Abstract] [Full Text] [Related]
24. Flecainide treatment of fetal tachycardia and hydrops fetalis in a twin pregnancy.
Gerli S; Clerici G; Mattei A; Di Renzo GC
Ultrasound Obstet Gynecol; 2006 Jul; 28(1):117. PubMed ID: 16736448
[No Abstract] [Full Text] [Related]
25. Treatment of fetal supraventricular tachycardia with maternal administration of digoxin.
Mozas J; Miranda JA; Barranco M
Int J Gynaecol Obstet; 1995 Sep; 50(3):293-4. PubMed ID: 8543115
[No Abstract] [Full Text] [Related]
26. Transplacental flecainide therapy for fetal supraventricular tachycardia in a twin pregnancy.
Edwards A; Peek MJ; Curren J
Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):110-2. PubMed ID: 10099764
[TBL] [Abstract][Full Text] [Related]
27. Resolution of hydrops fetalis despite persistent fetal tachycardia.
Silver LE; Platt LD; Santulli TV; Carlson DE
J Ultrasound Med; 2001 Oct; 20(10):1141-5. PubMed ID: 11587022
[No Abstract] [Full Text] [Related]
28. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum.
Agarwal A; Saha SC; Kaur A; Naganur S
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38154874
[TBL] [Abstract][Full Text] [Related]
29. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.
Parilla BV; Strasburger JF; Socol ML
Am J Perinatol; 1996 Nov; 13(8):483-6. PubMed ID: 8989479
[TBL] [Abstract][Full Text] [Related]
30. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
Campbell JQ; Best TH; Eswaran H; Lowery CL
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
[TBL] [Abstract][Full Text] [Related]
31. [Fetal supraventricular tachycardias and their treatment. Apropos of 23 cases].
Colin A; Chabaud JJ; Poinsot J; Boog G; Chantepie A; Le Fevre M; Bouhour JB; Almange C; Pezard PH
Arch Fr Pediatr; 1989 May; 46(5):335-40. PubMed ID: 2669675
[TBL] [Abstract][Full Text] [Related]
32. Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth: a case report.
Romeo E; D'Alto M; Russo MG; Sarubbi B; Cardaropoli D; Paladini D; Pacileo G; Annunziata A; Calabrò R
Ital Heart J; 2004 Oct; 5(10):777-80. PubMed ID: 15626276
[TBL] [Abstract][Full Text] [Related]
33. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
Miyoshi T; Maeno Y; Hamasaki T; Inamura N; Yasukochi S; Kawataki M; Horigome H; Yoda H; Taketazu M; Nii M; Hagiwara A; Kato H; Shimizu W; Shiraishi I; Sakaguchi H; Ueda K; Katsuragi S; Yamamoto H; Sago H; Ikeda T;
J Am Coll Cardiol; 2019 Aug; 74(7):874-885. PubMed ID: 31416531
[TBL] [Abstract][Full Text] [Related]
34. Neonatal flecainide toxicity following supraventricular tachycardia treatment.
Hall CM; Ward Platt MP
Ann Pharmacother; 2003 Sep; 37(9):1343-4. PubMed ID: 12921523
[No Abstract] [Full Text] [Related]
35. [Fetal supraventricular tachycardia. Management].
Amiel C; Chau C; Millet V; Agher JP; Gamerre M
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(3):284-8. PubMed ID: 8102147
[TBL] [Abstract][Full Text] [Related]
36. Flecainide as first-line treatment for fetal supraventricular tachycardia.
Ekiz A; Kaya B; Bornaun H; Acar DK; Avci ME; Bestel A; Yildirim G
J Matern Fetal Neonatal Med; 2018 Feb; 31(4):407-412. PubMed ID: 28114840
[TBL] [Abstract][Full Text] [Related]
37. An enhancement of coronary blood flow in a fetus with supraventricular tachycardia.
Uerpairojkit B; Manotaya S; Tanawattanacharoen S; Prechawat S; Charoenvidhya D
Prenat Diagn; 2009 Mar; 29(3):274-6. PubMed ID: 19165830
[No Abstract] [Full Text] [Related]
38. Fetal arrhythmias: natural history and management.
Vergani P; Mariani E; Ciriello E; Locatelli A; Strobelt N; Galli M; Ghidini A
Ultrasound Med Biol; 2005 Jan; 31(1):1-6. PubMed ID: 15653224
[TBL] [Abstract][Full Text] [Related]
39. Fetal supraventricular tachycardia, treating the baby by targeting the mother.
Husain A; Hubail Z; Al Banna R
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23592812
[TBL] [Abstract][Full Text] [Related]
40. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
